Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 open-label study of posaconazole in infants and children under 2 years with invasive fungal infection
MOH_2020-12-29_009358Phase 2Recruiting
- Sponsor
- Merck & Co.
- Start
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of posaconazole in invasive mycoses (2 cohorts), sponsored by Merck & Co. Started Dec 2020; status: recruiting.
02
Drugs
posaconazole
03
Conditions
invasive mycoses
Beyond the preview
Go deeper on MOH_2020-12-29_009358.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2020-12-29_009358.